Username Password
S&P 500: 2,093.57
Change: +0.10%

BIOGEN IDEC INC (BIIB)

Overview
Price 408.73
Price Change Today -$2.56 (-0.62%)
P&P rating Rating: 4
Open Price $412.24
Previous Close $411.29
Daily Range $405.79 - $413.70
52-Week Range $290.85 - $480.18
Volume 928
chart
Top Buy Analysis
BUY: BIIB Rating: 4
Company: BIOGEN IDEC INC
Points: 264.39
Start Price: $97.34
Start Date: 05/09/2011 11:45 PM
Neurodoc
Neurodoc
P&P Score: 99.58
Recs:
maybe the best of new oral MS meds in the pipeline

Comments: 0 | Comment

Top Sell Analysis
No Sell Analysis. Be the First.
Rate this Stock!
You haven't rated this stock yet!

What The Community Thinks

Total Players

50 Buy
0 Sell
 
Blog Posts
User User Score Date Title Comments Last Comment
rjm77me
99.98 12/23/14 BioTECH and Pharma / Drug manufactures being sold 1 12/23/14
rjm77me
99.98 07/23/14 If you have 100 stocks to watch during earning season = How will you track it 11 07/26/14
rjm77me
99.98 07/21/14 Zacks list of potential earning Beaters 6 07/24/14
rjm77me
99.98 04/24/14 Bio Tech leaders had lack luster earning results = $BIIB, AMGN, CELG 0
rjm77me
99.98 03/24/14 Charts, Stock Valuations some times have big divergences, In the end fundamentals have major influence 8 03/25/14
rjm77me
99.98 03/21/14 Momentum and Bio Tech on sale today 7 03/28/14
rjm77me
99.98 02/07/14 Is market ready to fly higher = coin toss between 2% gain or loss 0
rjm77me
99.98 11/07/13 Momentum stocks taken to wood shed today 4 11/20/13
rjm77me
99.98 06/12/13 $IBB head shoulder pattern confirmed 0
rjm77me
99.98 04/15/13 This was not a normal buy on pull back = it was a distribution day 3 04/21/13
Pages: [ 1 ]  2   3   4   5   ...  35  >>
Commentary
BUY: BIOGEN IDEC INC (BIIB) Rating: 4
Start Price: $137.04
Points: +140.92
Created: 05/15/2012
IDEC Pharmaceuticals Corporation is a biopharmaceutical company engaged primarily in the research, development and commercialization of targeted therapies for the treatment of cancer and autoimmune and inflammatory diseases.

Comments: 0 | Comment

Recs:
 
BUY: BIOGEN IDEC INC (BIIB) Rating: 4
Start Price: $137.04
Points: +139.84
Created: 05/15/2012
IDEC Pharmaceuticals Corporation is a biopharmaceutical company engaged primarily in the research, development and commercialization of targeted therapies for the treatment of cancer and autoimmune and inflammatory diseases.

Comments: 0 | Comment

Recs:
 
BUY: BIOGEN IDEC INC (BIIB) Rating: 4
Start Price: $137.04
Points: +140.92
Created: 05/15/2012
IDEC Pharmaceuticals Corporation is a biopharmaceutical company engaged primarily in the research, development and commercialization of targeted therapies for the treatment of cancer and autoimmune and inflammatory diseases.

Comments: 0 | Comment

Recs:
 
BUY: BIOGEN IDEC INC (BIIB) Rating: 4
Start Price: $137.04
Points: +139.84
Created: 05/15/2012
IDEC Pharmaceuticals Corporation is a biopharmaceutical company engaged primarily in the research, development and commercialization of targeted therapies for the treatment of cancer and autoimmune and inflammatory diseases.

Comments: 0 | Comment

Recs:
 
BUY: BIOGEN IDEC INC (BIIB) Rating: 4
Start Price: $137.04
Points: +140.92
Created: 05/15/2012
IDEC Pharmaceuticals Corporation is a biopharmaceutical company engaged primarily in the research, development and commercialization of targeted therapies for the treatment of cancer and autoimmune and inflammatory diseases.

Comments: 0 | Comment

Recs:
 
BUY: BIOGEN IDEC INC (BIIB) Rating: 4
Start Price: $137.04
Points: +139.84
Created: 05/15/2012
IDEC Pharmaceuticals Corporation is a biopharmaceutical company engaged primarily in the research, development and commercialization of targeted therapies for the treatment of cancer and autoimmune and inflammatory diseases.

Comments: 0 | Comment

Recs:
 
BUY: BIOGEN IDEC INC (BIIB) Rating: 4
Start Price: $97.34
Points: +264.39
Created: 05/09/2011
maybe the best of new oral MS meds in the pipeline

Comments: 0 | Comment

Recs:
 
BUY: BIOGEN IDEC INC (BIIB) Rating: 4
Start Price: $97.34
Points: +263.32
Created: 05/09/2011
maybe the best of new oral MS meds in the pipeline

Comments: 0 | Comment

Recs:
 
BUY: BIOGEN IDEC INC (BIIB) Rating: 4
Start Price: $97.34
Points: +264.39
Created: 05/09/2011
maybe the best of new oral MS meds in the pipeline

Comments: 0 | Comment

Recs:
 
BUY: BIOGEN IDEC INC (BIIB) Rating: 4
Start Price: $97.34
Points: +263.32
Created: 05/09/2011
maybe the best of new oral MS meds in the pipeline

Comments: 0 | Comment

Recs:
 
Pages: [ 1 ]  2   3   4   5  >>
Picks
Username P&P Score Call Time Frame Start Date Start Price Today (change) Stock Gain S&P Gain Points Analysis
JDShots 0.31 BUY One to Three Months 05/15/2012 $137.04 $408.73
(-0.62%)
+198.26% +57.33% +140.92 view
JDShots 0.31 BUY One to Three Months 05/15/2012 $137.04 $408.73
(-0.62%)
+198.26% +58.41% +139.84 view
JDShots 0.31 BUY One to Three Months 05/15/2012 $137.04 $408.73
(-0.62%)
+198.26% +57.33% +140.92 view
JDShots 0.31 BUY One to Three Months 05/15/2012 $137.04 $408.73
(-0.62%)
+198.26% +58.41% +139.84 view
JDShots 0.31 BUY One to Three Months 05/15/2012 $137.04 $408.73
(-0.62%)
+198.26% +57.33% +140.92 view
JDShots 0.31 BUY One to Three Months 05/15/2012 $137.04 $408.73
(-0.62%)
+198.26% +58.41% +139.84 view
vip 0.83 BUY One to Three Months 01/26/2012 $117.85 $408.73
(-0.62%)
+246.82% +58.79% +188.03
vip 0.83 BUY One to Three Months 01/26/2012 $117.85 $408.73
(-0.62%)
+246.82% +59.88% +186.94
vip 0.83 BUY One to Three Months 01/26/2012 $117.85 $408.73
(-0.62%)
+246.82% +58.79% +188.03
vip 0.83 BUY One to Three Months 01/26/2012 $117.85 $408.73
(-0.62%)
+246.82% +59.88% +186.94
Pages: [ 1 ]  2   3   4   5  >>
Sponsored Links